×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| Cian Healthcare Limited | NA | NA | NA | NA | 10.3 | |
| Vivanza Biosciences Limited | NA | NA | NA | NA | 9.48 | |
| ORTIN GLOBAL LIMITED | 0.81 | -1.75 | 0.4 | -0.22 | 9.06 |
Cian Healthcare Limited, with Security Code 542678, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2019 | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 29.7 | 29.4 | 27.6 | 38.5 | 33.8 | 37.0 | 27.1 | 34.8 | 32.7 | 30.6 |
| Expenses | 29.8 | 26.2 | 23.3 | 33.8 | 29.3 | 35.5 | 23.7 | 31.6 | 27.5 | 28.4 |
| Operating Profit | -0.1 | 3.2 | 4.3 | 4.8 | 4.6 | 1.5 | 3.4 | 3.3 | 5.2 | 2.2 |
| OPM % | -0.31% | 10.96% | 15.66% | 12.34% | 13.51% | 4.01% | 12.71% | 9.39% | 15.86% | 7.23% |
| Other Income | 0.6 | 0.1 | 0.7 | 0.0 | 0.2 | 0.1 | 0.4 | 0.4 | 0.2 | 0.9 |
| Interest | 2.7 | 2.9 | 2.9 | 2.8 | 3.4 | 2.6 | 2.5 | 2.4 | 1.8 | 2.4 |
| Depreciation | 1.8 | 1.6 | 0.8 | 1.2 | 1.2 | 1.3 | 1.3 | 1.8 | 1.8 | 1.8 |
| Profit before tax | -4.0 | -1.2 | 1.3 | 0.7 | 0.2 | -2.3 | 0.0 | -0.6 | 1.7 | -1.1 |
| Tax % | -26.1% | 0% | -11.7% | -35.6% | -141.2% | -0.2% | 4700% | -47.4% | -21.5% | 7.3% |
| Net Profit | -3.0 | -1.2 | 1.1 | 0.4 | 0.0 | -2.4 | 0.1 | -0.3 | 1.3 | -1.2 |
| EPS in Rs | -1.76 | -0.51 | 0.48 | 0.16 | -0.02 | -1.02 | 0.04 | -0.11 | 0.54 | -0.49 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | -1% |
| 3 Years: | -7% |
| TTM: | -26% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -13% |
| 5 Years: | -11% |
| 3 Years: | -2% |
| TTM: | -1669% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -26% |
| 3 Years: | -42% |
| 1 Year: | -83% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | -6% |
| TTM: | 27% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 53% |
| TTM: | -8600% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -26% |
| 3 Years: | -42% |
| 1 Year: | -83% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|